Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 206

1.

Hepatitis A transmission by factor IX concentrates.

Lawlor E, Graham S, Davidson E, Yap PL, Cunningham C, Daly H, Temperley IJ.

Vox Sang. 1996;71(2):126-8.

PMID:
8873425
[PubMed - indexed for MEDLINE]
2.

Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. The Italian Collaborative Group.

Mannucci PM, Gdovin S, Gringeri A, Colombo M, Mele A, Schinaia N, Ciavarella N, Emerson SU, Purcell RH.

Ann Intern Med. 1994 Jan 1;120(1):1-7.

PMID:
7504424
[PubMed - indexed for MEDLINE]
3.

Has hepatitis A virus been transmitted by clotting factor concentrates among hemophiliacs in the United States?

Mosley JW.

Vox Sang. 1994;67 Suppl 4:12-5; discussion 24-6. Review.

PMID:
7831863
[PubMed - indexed for MEDLINE]
4.

Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100 degrees C heat after lyophilization.

Santagostino E, Mannucci PM, Gringeri A, Azzi A, Morfini M, Musso R, Santoro R, Schiavoni M.

Transfusion. 1997 May;37(5):517-22.

PMID:
9149778
[PubMed - indexed for MEDLINE]
5.

A new cluster of hepatitis A infection in hemophiliacs traced to a contaminated plasma pool.

Chudy M, Budek I, Keller-Stanislawski B, McCaustland KA, Neidhold S, Robertson BH, Nübling CM, Seitz R, Löwer J.

J Med Virol. 1999 Feb;57(2):91-9.

PMID:
9892390
[PubMed - indexed for MEDLINE]
6.

FEIBA safety profile in multiple modes of clinical and home-therapy application.

Luu H, Ewenstein B.

Haemophilia. 2004 Sep;10 Suppl 2:10-6. Review.

PMID:
15385041
[PubMed - indexed for MEDLINE]
7.

Myocardial infarction after FEIBA therapy in a hemophilia-B patient with a factor IX inhibitor.

Mizon P, Goudemand J, Jude B, Marey A.

Ann Hematol. 1992 Jun;64(6):309-11.

PMID:
1637888
[PubMed - indexed for MEDLINE]
8.

Failure to detect hepatitis A virus RNA in factor VIII concentrates using the polymerase chain reaction. Results of a preliminary study.

McOmish F, Yap PL, Hart H, Peerlinck K, Burns SM, Simmonds P.

Vox Sang. 1994;67 Suppl 1:47-50.

PMID:
8091737
[PubMed - indexed for MEDLINE]
9.

Hepatitis A virus infection in tamarins: experimental transmission via contaminated factor VIII concentrates.

Chudy M, Stahl-Hennig C, Berger A, Nübling CM, Hunsmann G, Rabenau HF, Löwer J.

J Infect Dis. 2002 Apr 15;185(8):1170-3. Epub 2002 Mar 20.

PMID:
11930328
[PubMed - indexed for MEDLINE]
Free Article
10.

Prothrombin complex concentrates for clinical use.

Chandra S, Brummelhuis HG.

Vox Sang. 1981 Nov-Dec;41(5-6):257-73. Review.

PMID:
6798760
[PubMed - indexed for MEDLINE]
11.

An outbreak of hepatitis A among South African patients with hemophilia: evidence implicating contaminated factor VIII concentrate as the source.

Kedda MA, Kew MC, Cohn RJ, Field SP, Schwyzer R, Song E, Fernandes-Costa F.

Hepatology. 1995 Nov;22(5):1363-7.

PMID:
7590648
[PubMed - indexed for MEDLINE]
12.

Assessment for evidence of non A-non B hepatitis in patients given n-heptane-suspended heat-treated clotting factor concentrates.

Carnelli V, Gomperts ED, Friedman A, Aledort L, Hilgartner M, Dietrich S, Fedor EJ.

Thromb Res. 1987 Jun 15;46(6):827-34.

PMID:
3114910
[PubMed - indexed for MEDLINE]
13.

Multicenter retrospective study on the utilization of FEIBA in France in patients with factor VIII and factor IX inhibitors. French FEIBA Study Group. Factor Eight Bypassing Activity.

Negrier C, Goudemand J, Sultan Y, Bertrand M, Rothschild C, Lauroua P.

Thromb Haemost. 1997 Jun;77(6):1113-9.

PMID:
9241742
[PubMed - indexed for MEDLINE]
14.

Inactivation of hepatitis A virus in plasma products by vapor heating.

Barrett PN, Meyer H, Wachtel I, Eibl J, Dorner F.

Transfusion. 1997 Feb;37(2):215-20.

PMID:
9051099
[PubMed - indexed for MEDLINE]
15.

Clinical evaluation of viral safety of coagulation factor VIII and IX concentrates.

Mannucci PM.

Vox Sang. 1993;64(4):197-203. Review.

PMID:
8517048
[PubMed - indexed for MEDLINE]
16.

Hepatitis A virus sequence detected in clotting factor concentrates associated with disease transmission.

Robertson BH, Alter MJ, Bell BP, Evatt B, McCaustland KA, Shapiro CN, Sinha SD, Souci JM.

Biologicals. 1998 Jun;26(2):95-9. Review.

PMID:
9811512
[PubMed - indexed for MEDLINE]
17.

Prevalence of nucleic acid sequences specific for human parvoviruses, hepatitis A and hepatitis E viruses in coagulation factor concentrates.

Modrow S, Wenzel JJ, Schimanski S, Schwarzbeck J, Rothe U, Oldenburg J, Jilg W, Eis-Hübinger AM.

Vox Sang. 2011 May;100(4):351-8. doi: 10.1111/j.1423-0410.2010.01445.x. Epub 2010 Dec 7.

PMID:
21133933
[PubMed - indexed for MEDLINE]
18.

Hepatitis B virus associated DNA polymerase inactivation in factor IX concentrates.

Mitra G, Ng PK.

Thromb Res. 1986 Feb 1;41(3):291-300.

PMID:
3705011
[PubMed - indexed for MEDLINE]
19.
20.

Absence of hepatitis A virus transmission by high-purity solvent detergent treated coagulation factor concentrates in Scottish haemophiliacs.

Watson HG, Ludlam CA, McOmish F, Dennis R, Hart H, Simmonds P.

Br J Haematol. 1995 Jan;89(1):214-6.

PMID:
7833268
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk